• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Neocortical cholinergic neurons in elderly people.

作者信息

White P, Hiley C R, Goodhardt M J, Carrasco L H, Keet J P, Williams I E, Bowen D M

出版信息

Lancet. 1977 Mar 26;1(8013):668-71. doi: 10.1016/s0140-6736(77)92114-6.

DOI:10.1016/s0140-6736(77)92114-6
PMID:66473
Abstract

Choline acetyltransferase activity (presynaptic cholinergic system) and high affinity binding of cholinergic antagonists (postsynaptic cholinergic system) were measured in brain tissue removed after death from both mentally normal and demented old people. Muscarinic receptor binding sites in frontal cortex decreased with advancing years only in old people without appreciable morphological evidence of senile degeration. Preliminary data for temporal lobe suggested that also in Pick's disease the density of receptor binding sites is reduced. The markers are not significantly reduced in cases of mixed senile and vascular dementia. However, in non-vascular senile dementia of the Alzheimer type, there were indications that the presynaptic marker is selectively depleted. Therefore, centrally acting anticholinesterases might be beneficial, particularly in the early stages of the disease.

摘要

相似文献

1
Neocortical cholinergic neurons in elderly people.
Lancet. 1977 Mar 26;1(8013):668-71. doi: 10.1016/s0140-6736(77)92114-6.
2
Lack of cholinergic deficit in the neocortex in Pick's disease.
Prog Neuropsychopharmacol Biol Psychiatry. 1983;7(4-6):725-7. doi: 10.1016/0278-5846(83)90053-2.
3
Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients.痴呆患者活检额叶新皮质的胆碱乙酰转移酶活性与组织病理学
J Neurol Sci. 1982 Dec;57(2-3):191-202. doi: 10.1016/0022-510x(82)90026-0.
4
The temporal lobe in dementia of Alzheimer's type.阿尔茨海默病型痴呆中的颞叶。
Gerontology. 1983;29(5):320-4. doi: 10.1159/000213133.
5
Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.老年痴呆症中胆碱能异常与老年斑及心理测试分数的相关性
Br Med J. 1978 Nov 25;2(6150):1457-9. doi: 10.1136/bmj.2.6150.1457.
6
Biochemical changes in the cholinergic system of the ageing brain and in senile dementia.
Psychol Med. 1980 May;10(2):315-9. doi: 10.1017/s003329170004407x.
7
Necropsy evidence of central cholinergic deficits in senile dementia.老年痴呆症中枢胆碱能缺陷的尸检证据。
Lancet. 1977 Jan 22;1(8004):189. doi: 10.1016/s0140-6736(77)91780-9.
8
Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease.路易体痴呆中的胆碱能递质与神经营养活性:与帕金森病的相似性及与阿尔茨海默病的区别
Alzheimer Dis Assoc Disord. 1993 Summer;7(2):69-79. doi: 10.1097/00002093-199307020-00002.
9
A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease.阿尔茨海默病与皮克病皮质胆碱能系统的尸检比较。
J Neurol Sci. 1983 Dec;62(1-3):211-7. doi: 10.1016/0022-510x(83)90200-9.
10
Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer's disease.在阿尔茨海默病的临床前阶段,突触前后皮质胆碱能缺失与淀粉样斑块的存在和密度成正比。
Acta Neuropathol. 2011 Jul;122(1):49-60. doi: 10.1007/s00401-011-0831-1. Epub 2011 May 1.

引用本文的文献

1
Monoclonal antibodies and aptamers: The future therapeutics for Alzheimer's disease.单克隆抗体与适配体:阿尔茨海默病的未来疗法。
Acta Pharm Sin B. 2024 Jul;14(7):2795-2814. doi: 10.1016/j.apsb.2024.03.034. Epub 2024 Apr 17.
2
The advent of Alzheimer treatments will change the trajectory of human aging.阿尔茨海默病治疗方法的出现将改变人类衰老的轨迹。
Nat Aging. 2024 Apr;4(4):453-463. doi: 10.1038/s43587-024-00611-5. Epub 2024 Apr 19.
3
Cholinergic Antagonists and Behavioral Disturbances in Neurodegenerative Diseases.胆碱能拮抗剂与神经退行性疾病中的行为障碍。
Int J Mol Sci. 2023 Apr 7;24(8):6921. doi: 10.3390/ijms24086921.
4
The Broad Range of Research in Alzheimer's Disease and Related Dementias.阿尔茨海默病及相关痴呆症的广泛研究范围。
Neurotherapeutics. 2022 Jan;19(1):1-7. doi: 10.1007/s13311-022-01245-4. Epub 2022 May 13.
5
Diclofenac reduces the risk of Alzheimer's disease: a pilot analysis of NSAIDs in two US veteran populations.双氯芬酸降低阿尔茨海默病风险:对美国两个退伍军人队列中使用非甾体抗炎药的初步分析
Ther Adv Neurol Disord. 2020 Jun 25;13:1756286420935676. doi: 10.1177/1756286420935676. eCollection 2020.
6
Atrophy of Basal Forebrain Initiates with Tau Pathology in Individuals at Risk for Alzheimer's Disease.基底前脑萎缩始于阿尔茨海默病风险个体的 Tau 病理学。
Cereb Cortex. 2020 Apr 14;30(4):2083-2098. doi: 10.1093/cercor/bhz224.
7
History and progress of hypotheses and clinical trials for Alzheimer's disease.阿尔茨海默病假说和临床试验的历史与进展。
Signal Transduct Target Ther. 2019 Aug 23;4:29. doi: 10.1038/s41392-019-0063-8. eCollection 2019.
8
Basal forebrain cholinergic system volume is associated with general cognitive ability in the elderly.基底前脑胆碱能系统体积与老年人的一般认知能力有关。
Neuropsychologia. 2018 Oct;119:145-156. doi: 10.1016/j.neuropsychologia.2018.08.005. Epub 2018 Aug 7.
9
The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia.抗胆碱能药物负担对精神分裂症患者认知表现的影响。
J Clin Psychopharmacol. 2017 Dec;37(6):651-656. doi: 10.1097/JCP.0000000000000790.
10
A Review of Biomarkers for Neurodegenerative Disease: Will They Swing Us Across the Valley?神经退行性疾病生物标志物综述:它们能引领我们跨越难关吗?
Neurol Ther. 2017 Jul;6(Suppl 1):5-13. doi: 10.1007/s40120-017-0072-x. Epub 2017 Jul 21.